Loading…
Groupe Cyrenne Inc. dba HomeoAnimal was cited for manufacturing and selling multiple unapproved new animal drugs through their website and social media, including products claiming to treat or prevent diseases such as cancer, heartworm, seizures, and COVID-19 in animals. The company violated the Federal Food, Drug, and Cosmetic Act by introducing these products into interstate commerce without FDA approval, despite making disease claims that established them as drugs under federal law. The violations were identified during an FDA review of the company's website from December 2020 through March 2021, which documented numerous therapeutic claims for products including Immunopet, Silverpet, Parvopet, and Thyroidpet.